Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01552863 · ClinicalTrials.gov registry record · Phase 1
A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers
A Phase 1 study, sponsored by Pain Therapeutics.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT01552863 is a Phase 1 study that has completed, run by Pain Therapeutics. The registered enrollment target is 21 participants.
The verdict
NCT01552863, a Phase 1 study, has completed, sponsored by Pain Therapeutics.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
This is an open-label (both the physician and healthy volunteer know which medication will be administered), single-dose, 6- dosing period study to characterize the pharmacokinetics of oxycodone (process by which oxycodone is absorbed, distributed, metabolized, and eliminated by the body). This study will consist of three parts that will take place over approximately 90 days. Part 1 of the study has 4 dosing periods, while Parts 2 and 3 have one dosing period each.
Interventions
- DRUG Oxycodone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2012-03 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01552863
The ClinicalTrials.gov registry entry for NCT01552863 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pain Therapeutics, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Oxycodone is the first listed.
NCT01552863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01552863 about?
NCT01552863 is a clinical study titled "A Study To Characterize The Pharmacokinetics Of Oxycodone In Healthy Volunteers". This is an open-label (both the physician and healthy volunteer know which medication will be administered), single-dose, 6- dosing period study to characterize the pharmacokinetics of oxycodone (process by which oxycodone is absorbed, distributed, metabolized, and eliminated by the body). This stud...
What is the current status of trial NCT01552863?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2012-03. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01552863?
The interventions under investigation include: Oxycodone (DRUG).
Who is sponsoring clinical trial NCT01552863?
This trial is sponsored by Pain Therapeutics, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.